IPSEN |
Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
| 123,50 EUR | -1,12% |
|
+4,04% | +11,56% |
| 02/01 | Un pessimo 2024 aumenta le probabilità di un 2025 più luminoso. |  |
| 31/12 | IPSEN : AlphaValue/Baader Europe conferma il rating Buy | ZM |
Gruppo Ipsen: grafico delle relazioni
Scoietà private appartenenti allo stesso gruppo di IPSEN
| Società | Manager |
|---|---|
| Socapharma SAS | - |
Ipsen Pharma Biotech SAS
 Ipsen Pharma Biotech SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma Biotech SAS engages in the pharmaceutical industry. It offers drugs to treat neurology, endocrinology, uro-oncology, hematology, gastroenterology, cardiovascular, and cognitive disorders. The company is headquartered in Signes, France. | Vincent Berny |
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Aymeric Le Chatelier |
MarketScreener is also available in this country: United States.
Switch edition
Rimanere sul sito del Paese attuale